IHT Wealth Management’s iRadimed IRMD Stock Holding History

IHT Wealth Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-105	Closed	-$1K	–	1433
2017 Q1	$1K	Hold	105	–	–	﹤0.01%	1172
2016 Q4	$1K	Buy	+105	New	+$1.13K	﹤0.01%	1123

Other funds holding IRMD

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

IHT Wealth Management's IRMD Position: Q2 2017 in Review

IHT Wealth Management sold out of iRadimed (IRMD) in Q2 2017, closing a stake of 105 shares — an estimated $1K sold.

IHT Wealth Management first reported a position in IRMD in Q4 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2017. 35 funds tracked by Wall St. Rank hold IRMD as of Q2 2017.

IHT Wealth Management reported no remaining iRadimed position as of Q2 2017 after selling out during the quarter.
IHT Wealth Management sold 105 iRadimed shares in Q2 2017, an estimated $1K.
IHT Wealth Management first reported a position in iRadimed in Q4 2016 and held it in 2 quarters.
IHT Wealth Management's iRadimed position peaked at $1K in Q1 2017.
35 funds tracked by Wall St. Rank held iRadimed as of Q2 2017.

Based on IHT Wealth Management's 13F filing for Q2 2017, filed 14 Aug 2017.